EBMT 2018 | How to define and treat high-risk lymphoma

Andrés Ferreri

Dividing patients into subgroups for different therapies can often be quite difficult. In this interview, recorded at the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Andrés Ferreri, MD, of IRCCS San Raffaele Hospital, Milan, Italy, outlines the difficulties that still exist today with regards to classifying patients as high-risk, and mentions improvements that must be made in geriatric cases to improve the efficacy of treatment in the elderly.

Share this video